positionForPages[112]={page:112,positions:[{w:"102",p:[0.014976,0.039294,0.054134,0.039294,0.054134,0.019261,0.014976,0.019261,0.000000,0.000000,0.000000]},{w:"TreaTmenT approaches",p:[0.097196,0.039084,0.362673,0.039084,0.362673,0.019649,0.097196,0.019649,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"MIMS ConCISe GuIde to CardIovaSCular, MetabolIC and endoCrIne dISeaSeS ",p:[0.097141,0.974259,0.701335,0.974259,0.701335,0.960936,0.097141,0.960936,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" ",p:[0.701335,0.974259,0.705081,0.974259,0.705081,0.960936,0.701335,0.960936,0.000000]},{w:"VOLUME 1",p:[0.705252,0.974259,0.786566,0.974259,0.786566,0.959690,0.705252,0.959690,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"REFERENCES",p:[0.097162,0.096905,0.209807,0.096905,0.209807,0.080514,0.097162,0.080514,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"1.   nagtegaal Id, ",p:[0.096970,0.110791,0.223302,0.110791,0.223302,0.097468,0.096970,0.097468,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.224773,0.110791,0.256211,0.110791,0.256211,0.097703,0.224773,0.097703,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" the 2019 WHo classification of ",p:[0.256211,0.110791,0.479474,0.110791,0.479474,0.097468,0.256211,0.097468,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"tumours of the digestive system. ",p:[0.127261,0.125043,0.368758,0.125043,0.368758,0.111720,0.127261,0.111720,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Histopathology.",p:[0.372777,0.125043,0.475763,0.125043,0.475763,0.111955,0.372777,0.111955,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" ",p:[0.475763,0.125043,0.479509,0.125043,0.479509,0.111720,0.475763,0.111720,0.000000]},{w:"2020;76(2):182-188.",p:[0.127261,0.139295,0.258862,0.139295,0.258862,0.125972,0.127261,0.125972,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"2.   Pavel  M, ",p:[0.096952,0.153548,0.189230,0.153548,0.189230,0.140224,0.096952,0.140224,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.192138,0.153548,0.224756,0.153548,0.224756,0.140460,0.192138,0.140460,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" Gastroenteropancreatic neoplasms: ",p:[0.224756,0.153548,0.479491,0.153548,0.479491,0.140224,0.224756,0.140224,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"eSMo clinical practice guidelines  for diagnosis, ",p:[0.127261,0.167800,0.479509,0.167800,0.479509,0.154477,0.127261,0.154477,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"treatment  and  follow-up. ",p:[0.127261,0.182052,0.327143,0.182052,0.327143,0.168729,0.127261,0.168729,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Ann Oncol.",p:[0.340125,0.182052,0.422654,0.182052,0.422654,0.168964,0.340125,0.168964,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"  2020. ",p:[0.422654,0.182052,0.479474,0.182052,0.479474,0.168729,0.422654,0.168729,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"online first article. doi:  https://doi.org/10.1016/j.",p:[0.127261,0.196304,0.475746,0.196304,0.475746,0.182981,0.127261,0.182981,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"annonc.2020.03.304.",p:[0.127261,0.210557,0.266097,0.210557,0.266097,0.197233,0.127261,0.197233,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"3.   barrio M, ",p:[0.096952,0.224809,0.192070,0.224809,0.192070,0.211486,0.096952,0.211486,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.193695,0.224809,0.225252,0.224809,0.225252,0.211721,0.193695,0.211721,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" the impact of somastatin receptor-",p:[0.225252,0.224809,0.475728,0.224809,0.475728,0.211486,0.225252,0.211486,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"directed Pet/Ct on the management of patients ",p:[0.127244,0.239061,0.479440,0.239061,0.479440,0.225738,0.127244,0.225738,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"with neuro-endocrine tumor: a systematic review ",p:[0.127244,0.253313,0.479491,0.253313,0.479491,0.239990,0.127244,0.239990,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"and meta-analysis. 2017;58(5):756-761.",p:[0.127244,0.267565,0.388000,0.267565,0.388000,0.254242,0.127244,0.254242,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"4.   lawal Io, ",p:[0.096935,0.281818,0.191454,0.281818,0.191454,0.268494,0.096935,0.268494,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.191557,0.281818,0.221866,0.281818,0.221866,0.268730,0.191557,0.268730,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" Gallium-68-dotatate Pet/Ct is better ",p:[0.221866,0.281818,0.479457,0.281818,0.479457,0.268494,0.221866,0.268494,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"than Ct in the management of somatostatin ",p:[0.127227,0.296070,0.479474,0.296070,0.479474,0.282747,0.127227,0.282747,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"expressing tumors: First experience in africa. ",p:[0.127227,0.310322,0.435704,0.310322,0.435704,0.296999,0.127227,0.296999,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"J Nucl ",p:[0.436440,0.310322,0.478790,0.310322,0.478790,0.297234,0.436440,0.297234,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Med.",p:[0.127227,0.324574,0.158750,0.324574,0.158750,0.311486,0.127227,0.311486,0.000000,0.000000,0.000000,0.000000]},{w:" 2017;20(2):128-133.",p:[0.158750,0.324574,0.294097,0.324574,0.294097,0.311251,0.158750,0.311251,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"5.   luo  Y, ",p:[0.096918,0.338827,0.177326,0.338827,0.177326,0.325503,0.096918,0.325503,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.185040,0.338827,0.221609,0.338827,0.221609,0.325739,0.185040,0.325739,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" Glucagon-like peptide-1 receptor ",p:[0.221609,0.338827,0.479474,0.338827,0.479474,0.325503,0.221609,0.325503,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Pet/Ct with  Ga-nota-exendin-4 for detecting ",p:[0.127227,0.353079,0.479512,0.353098,0.479512,0.339774,0.127227,0.339756,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"68",p:[0.226419,0.347956,0.236152,0.347956,0.236152,0.340188,0.226419,0.340188,0.000000,0.000000]},{w:"localized insulinoma:  a prospective cohort study. ",p:[0.127265,0.367350,0.479512,0.367350,0.479512,0.354027,0.127265,0.354027,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" ",p:[0.475749,0.367350,0.479495,0.367350,0.479495,0.354027,0.475749,0.354027,0.000000]},{w:"J Nucl Med.",p:[0.127265,0.381602,0.200540,0.381602,0.200540,0.368514,0.127265,0.368514,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2016;57(5):715-720.",p:[0.200540,0.381602,0.335887,0.381602,0.335887,0.368279,0.200540,0.368279,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"6.   Modlin  IM, ",p:[0.096956,0.395854,0.208100,0.395854,0.208100,0.382531,0.096956,0.382531,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.213317,0.395854,0.247834,0.395854,0.247834,0.382766,0.213317,0.382766,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"  the  netest:  the clinical utility ",p:[0.247834,0.395854,0.479495,0.395854,0.479495,0.382531,0.247834,0.382531,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"of multigene blood analysis in the diagnosis ",p:[0.127265,0.410106,0.479530,0.410106,0.479530,0.396783,0.127265,0.396783,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"and management of neuroendocrine tumors. ",p:[0.127265,0.424359,0.479495,0.424359,0.479495,0.411035,0.127265,0.411035,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Endocrinol Metab Clin N Am.",p:[0.127265,0.438611,0.313412,0.438611,0.313412,0.425523,0.127265,0.425523,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2018;47:485-504.",p:[0.313412,0.438611,0.431347,0.438611,0.431347,0.425288,0.313412,0.425288,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"7.   Modlin  I, ",p:[0.096956,0.452863,0.192878,0.452863,0.192878,0.439540,0.096956,0.439540,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et  al.",p:[0.196196,0.452863,0.229139,0.452863,0.229139,0.439775,0.196196,0.439775,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" Gut neuroendocrine tumor blood ",p:[0.229139,0.452863,0.479478,0.452863,0.479478,0.439540,0.229139,0.439540,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"qPCr  fingerprint assay: Characteristics  and ",p:[0.127265,0.467115,0.479495,0.467115,0.479495,0.453792,0.127265,0.453792,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"reproducibility. ",p:[0.127265,0.481368,0.232765,0.481368,0.232765,0.468044,0.127265,0.468044,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Clin Chem.",p:[0.232765,0.481368,0.302859,0.481368,0.302859,0.468280,0.232765,0.468280,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2014;52(3):419-429.",p:[0.302859,0.481368,0.438205,0.481368,0.438205,0.468044,0.302859,0.468044,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"8.   bodei  l, ",p:[0.096956,0.495620,0.195341,0.495620,0.195341,0.482297,0.096956,0.482297,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.205193,0.495620,0.244225,0.495620,0.244225,0.482532,0.205193,0.482532,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" Prrt neuroendocrine tumor ",p:[0.244396,0.495620,0.479495,0.495620,0.479495,0.482297,0.244396,0.482297,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"response monitored using circulating transcript ",p:[0.127248,0.509872,0.479478,0.509872,0.479478,0.496549,0.127248,0.496549,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"analysis: the netest. ",p:[0.554515,0.095429,0.702776,0.095429,0.702776,0.082105,0.554515,0.082105,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Eur J Nucl Med Mol Imaging.",p:[0.705256,0.095429,0.903033,0.095429,0.903033,0.082341,0.705256,0.082341,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" ",p:[0.903016,0.095429,0.906762,0.095429,0.906762,0.082105,0.903016,0.082105,0.000000]},{w:"2020;47(4):895-906.",p:[0.554532,0.110234,0.689212,0.110234,0.689212,0.096910,0.554532,0.096910,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"9.   Kulke  MH, ",p:[0.524223,0.125039,0.632477,0.125039,0.632477,0.111715,0.524223,0.111715,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.638925,0.125039,0.674451,0.125039,0.674451,0.111950,0.638925,0.111950,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"  telotristat ethyl, a tryptophan ",p:[0.674451,0.125039,0.906762,0.125039,0.906762,0.111715,0.674451,0.111715,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"hydroxylase inhibitor for the treatment of carcinoid ",p:[0.554532,0.139843,0.906745,0.139843,0.906745,0.126520,0.554532,0.126520,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"syndrome. ",p:[0.554532,0.154648,0.629723,0.154648,0.629723,0.141325,0.554532,0.141325,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"J Clin Oncol.",p:[0.629723,0.154648,0.708625,0.154648,0.708625,0.141560,0.629723,0.141560,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2017;35:14-23.",p:[0.708625,0.154648,0.809866,0.154648,0.809866,0.141325,0.708625,0.141325,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"10.   Strosberg J, ",p:[0.524223,0.169453,0.638053,0.169453,0.638053,0.156130,0.524223,0.156130,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.639968,0.169453,0.671765,0.169453,0.671765,0.156365,0.639968,0.156365,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" Phase 3 trial of (177)lu-dotatate ",p:[0.671765,0.169453,0.906762,0.169453,0.906762,0.156130,0.671765,0.156130,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"for mid-gut neuroendocrine tumors. ",p:[0.554532,0.184258,0.811217,0.184258,0.811217,0.170935,0.554532,0.170935,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"N Engl J Med.",p:[0.813030,0.184258,0.903051,0.184258,0.903051,0.171170,0.813030,0.171170,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" ",p:[0.903051,0.184258,0.906796,0.184258,0.906796,0.170935,0.903051,0.170935,0.000000]},{w:"2017;376(2):125-135.",p:[0.554532,0.199063,0.694480,0.199063,0.694480,0.185740,0.554532,0.185740,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"11.   Strosberg  J, ",p:[0.524223,0.213868,0.639746,0.213868,0.639746,0.200545,0.524223,0.200545,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.643355,0.213868,0.676538,0.213868,0.676538,0.200780,0.643355,0.200780,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" Health-related quality of life in ",p:[0.676538,0.213868,0.906762,0.213868,0.906762,0.200545,0.676538,0.200545,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"patients with progressive midgut neuroendocrine ",p:[0.554532,0.228673,0.906762,0.228673,0.906762,0.215350,0.554532,0.215350,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"tumors treated with  lu-dotatate in the phase III ",p:[0.554532,0.243478,0.906790,0.243453,0.906790,0.230130,0.554532,0.230155,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"177",p:[0.698604,0.238311,0.713203,0.238311,0.713203,0.230544,0.698604,0.230544,0.000000,0.000000,0.000000]},{w:"netter-1 trial. ",p:[0.554542,0.258258,0.656262,0.258258,0.656262,0.244934,0.554542,0.244934,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"J Clin Oncol.",p:[0.656262,0.258258,0.735164,0.258258,0.735164,0.245170,0.656262,0.245170,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2018;36(25):2578-2584.",p:[0.735164,0.258258,0.895552,0.258258,0.895552,0.244934,0.735164,0.244934,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"12.   lawal  I, ",p:[0.524233,0.273063,0.612099,0.273063,0.612099,0.259739,0.524233,0.259739,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.616494,0.273063,0.650344,0.273063,0.650344,0.259975,0.616494,0.259975,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"  the College of  nuclear Physicians ",p:[0.650344,0.273063,0.906790,0.273063,0.906790,0.259739,0.650344,0.259739,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"of South  africa practice guidelines on peptide ",p:[0.554542,0.287868,0.906755,0.287868,0.906755,0.274544,0.554542,0.274544,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"receptor radionuclide therapy in neuroendocrine ",p:[0.554542,0.302672,0.906755,0.302672,0.906755,0.289349,0.554542,0.289349,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"tumours. ",p:[0.554542,0.317477,0.619060,0.317477,0.619060,0.304154,0.554542,0.304154,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"S Afr J Surg.",p:[0.619060,0.317477,0.692335,0.317477,0.692335,0.304389,0.619060,0.304389,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2018;56(3):55-64.",p:[0.692335,0.317477,0.810988,0.317477,0.810988,0.304154,0.692335,0.304154,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"13.   Claringbold  PG, ",p:[0.524233,0.332282,0.673794,0.332282,0.673794,0.318959,0.524233,0.318959,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.683475,0.332282,0.721669,0.332282,0.721669,0.319194,0.683475,0.319194,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"  neuroendocrine tumor ",p:[0.721669,0.332282,0.906772,0.332282,0.906772,0.318959,0.721669,0.318959,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"control: durable objective response to combination ",p:[0.554525,0.347087,0.906738,0.347087,0.906738,0.333764,0.554525,0.333764,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"177",p:[0.554545,0.356725,0.570360,0.356725,0.570360,0.348958,0.554545,0.348958,0.000000,0.000000,0.000000]},{w:"lu-octreotate-capecitabine-temozolomide ",p:[0.570968,0.361867,0.906778,0.361867,0.906778,0.348544,0.570968,0.348544,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"radiopeptide chemotherapy. ",p:[0.554548,0.376672,0.760313,0.376672,0.760313,0.363349,0.554548,0.363349,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Neuroendocrinology. ",p:[0.767121,0.376672,0.906111,0.376672,0.906111,0.363584,0.767121,0.363584,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"2016;103(5):432-439. ",p:[0.554548,0.391477,0.698242,0.391477,0.698242,0.378154,0.554548,0.378154,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"14.   Purohit  nK, ",p:[0.524239,0.406282,0.638069,0.406282,0.638069,0.392958,0.524239,0.392958,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.641968,0.406282,0.675390,0.406282,0.675390,0.393194,0.641968,0.393194,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" Potentiation of ",p:[0.675390,0.406282,0.791649,0.406282,0.791649,0.392958,0.675390,0.392958,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"177",p:[0.795556,0.401130,0.810154,0.401130,0.810154,0.393363,0.795556,0.393363,0.000000,0.000000,0.000000]},{w:"lu-octreotate ",p:[0.810154,0.406272,0.906777,0.406272,0.906777,0.392949,0.810154,0.392949,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"peptide receptor radionuclide therapy of human ",p:[0.554547,0.421077,0.906811,0.421077,0.906811,0.407754,0.554547,0.407754,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"neuroendocrine tumor cells by ParP inhibitor. ",p:[0.554547,0.435882,0.906777,0.435882,0.906777,0.422559,0.554547,0.422559,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"Oncotarget.",p:[0.554547,0.450687,0.632286,0.450687,0.632286,0.437599,0.554547,0.437599,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:" 2018;9(37):24693-24706.",p:[0.632286,0.450687,0.801020,0.450687,0.801020,0.437364,0.632286,0.437364,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"15.   Frilling  a, ",p:[0.524238,0.465492,0.630319,0.465492,0.630319,0.452168,0.524238,0.452168,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"et al.",p:[0.640205,0.465492,0.678553,0.465492,0.678553,0.452404,0.640205,0.452404,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"  radioembolisation  with  90Y ",p:[0.678553,0.465492,0.906760,0.465492,0.906760,0.452168,0.678553,0.452168,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"microspheres for neuroendocrine liver metastases: ",p:[0.554547,0.480297,0.906760,0.480297,0.906760,0.466973,0.554547,0.466973,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"an institutional case series, systematic review and ",p:[0.554547,0.495102,0.906777,0.495102,0.906777,0.481778,0.554547,0.481778,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"meta-analysis. ",p:[0.554547,0.509906,0.653718,0.509906,0.653718,0.496583,0.554547,0.496583,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]},{w:"HPB",p:[0.653718,0.509906,0.680383,0.509906,0.680383,0.496818,0.653718,0.496818,0.000000,0.000000,0.000000]},{w:" (oxford). 2019;21(7):773-783.",p:[0.680383,0.509906,0.877734,0.509906,0.877734,0.496583,0.680383,0.496583,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000]}]};